Systematic review: the liver in coeliac disease

Aliment Pharmacol Ther. 2005 Mar 1;21(5):515-8. doi: 10.1111/j.1365-2036.2005.02361.x.

Abstract

Background: For over a decade isolated reports have noted liver histology and biochemistry changes in patients with coeliac disease. The prevalence and response to treatment is clinically important.

Aim: To outline the frequency and significance of liver abnormalities in coeliac disease.

Methods: A Medline search using Ovid-Coeliac/Coeliac (exp) and liver disease (exp) was completed of English references published during 1966-June 2003. Bibliographic references and other appropriate sources were also searched.

Results: Six studies reported liver biochemistry in 591 patients; 248 patients had abnormal results. Elevated transaminases were the most frequently reported abnormality. A gluten-free diet produced resolution of elevated transaminases in 115 of 130 patients. There was a greater than expected association with primary biliary cirrhosis and advanced liver disease.

Conclusions: Mildly abnormal liver biochemistry is frequent in untreated coeliac disease and may provide a key to the diagnosis. Routine investigations for undiagnosed liver disease should include tissue transglutaminase testing. Left untreated, coeliac-induced hepatitis may rarely progress to end-stage liver disease. Primary biliary cirrhosis is clearly linked to coeliac disease. The full story of these linkages is yet to be written.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Celiac Disease / complications*
  • Humans
  • Liver / enzymology
  • Liver Diseases / enzymology
  • Liver Diseases / etiology*
  • Liver Function Tests